- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03401333
Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use (STAR)
October 22, 2018 updated by: Yale University
Feasibility of Augmenting Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use
This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale New Haven Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 13 to 18 years old
- Able to provide consent or assent and parental permission
- have a functioning cell phone without pay-as-you-go text messaging
Exclusion Criteria:
- currently enrolled in any substance abuse program;
- have medical/psychiatric condition that precludes participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Text messaging and brief intervention
Brief motivational interview and 4-weeks of text messaging.
|
An in-person brief motivational intervention coupled with 4 weeks of motivational text messages
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Enrollment
Time Frame: Baseline
|
Number of participants per month that enroll in the study
|
Baseline
|
Retention
Time Frame: 4 weeks
|
% of enrolled participants that complete the 4-week follow up assessments
|
4 weeks
|
Satisfaction
Time Frame: 4 weeks
|
Participant's rating of how much they like the intervention (Likert scale)
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 14, 2017
Primary Completion (Actual)
June 6, 2018
Study Completion (Actual)
June 6, 2018
Study Registration Dates
First Submitted
January 9, 2018
First Submitted That Met QC Criteria
January 16, 2018
First Posted (Actual)
January 17, 2018
Study Record Updates
Last Update Posted (Actual)
October 23, 2018
Last Update Submitted That Met QC Criteria
October 22, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000021254
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
Boston University Charles River CampusRecruiting
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
University of ArkansasRecruitingDrinking Behavior | Drinking Excessive | DrinkingUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Universidad de GranadaCompletedExercise | Drinking, AlcoholSpain
-
Lehigh UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brown UniversityCompletedCollege DrinkingUnited States
Clinical Trials on Text Messaging and Brief Negotiation Interview
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Hunter College of City University of New YorkRecruitingAlcohol ConsumptionUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHazardous Drinking | Harmful DrinkingUnited States
-
Brown UniversityRecruitingAlcohol Drinking | HIV ViremiaUnited States
-
Penn State UniversityRecruitingWeight Gain | Physical InactivityUnited States
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
Brown UniversityActive, not recruitingAlcohol Drinking | HIVUnited States
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingGestational DiabetesHong Kong
-
Duke UniversityThe George Institute for Global Health, ChinaCompleted
-
Yale UniversityCompletedBreast Cancer | Adherence, Medication | Side EffectUnited States